Characteristics of the respondents (n = 2,151). by Mohammad Delwer Hossain Hawlader (11558838)

“…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”

Determinants of HPV vaccine acceptance. by Mohammad Delwer Hossain Hawlader (11558838)

“…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”

Temporal analysis of HSV-1 infection using the dual-fluorescent timestamp virus. by Kamal L. Nahas (13014698)

Imaging Flow Cytometry reveals a change in expression of Tc24 and SSP4 during different infection timepoints of <i>T</i>. <i>cruzi</i>. by Leroy Versteeg (4248760)

Total number of hospitalizations and hospitalization rates for HAV infection by age groups in Mexico throughout the observation period (2000–2019). by Adriana Guzman-Holst (7906868)

Deaths due to HAV infection by year and age group in Mexico throughout the observation period (2000–2019). by Adriana Guzman-Holst (7906868)

DataSheet1_Identification of circulating metabolites linked to the risk of breast cancer: a mendelian randomization study.CSV by Xiaosheng Zhu (9101853)

“…Notably, acetate (OR = 1.12, P = 0.03), HDL cholesterol (OR = 1.09, P < 0.001), ration of omega-6 fatty acids to total fatty acids ratio (OR = 1.09, P = 0.01), and phospholipids in large LDL (OR = 1.09, P < 0.001) were linked to an increased risk of ER + breast cancer, while linoleic acid (OR = 0.91, P < 0.001) monounsaturated fatty acids (OR = 0.91, P < 0.001), and total lipids in LDL (OR = 0.91, P < 0.001) were associated with a decreased risk. …”

Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

“…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”

Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

“…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”

The heterogenous morphology of mitochondria. by Kamal L. Nahas (13014698)

Fragmentation and dispersal of <i>cis</i>-Golgi membranes during HSV-1 infection. by Kamal L. Nahas (13014698)

Fragmentation and dispersal of <i>trans</i>-Golgi membranes during HSV-1 infection. by Kamal L. Nahas (13014698)

Information on coral juvenile abundances and percentage hard coral cover at Aldabra between 2014 and 2019. by Anna Koester (11805572)

Viewing order distribution of 4 test sets among the 2 participant groups. by Michelle Noga (3637138)

Subjects:

Summary of type 2 errors by type of case (all cases, complex, simple), participant type (all, trainee, experienced), and p values. by Michelle Noga (3637138)

Subjects:

Time (in seconds) spent by each participant per case. by Michelle Noga (3637138)

Subjects:

Errors in identifying PVS and localization of veins for monoscopic and stereoscopic images for complex scans with 3 or more PVS lesions. by Michelle Noga (3637138)

Subjects:

Errors in identifying PVS and localization of veins for monoscopic and stereoscopic images. by Michelle Noga (3637138)

Subjects:

CD4+ (A) and CD8+ (B) T cell responses in pre-pandemic Ugandan PBMC samples (n = 29). by Annemarie Namuniina (16496648)

Reportable range of qPCR assays targeting <i>T. cruzi</i> satDNA (A) and mouse GAPDH (B). by Glaucia Vilar-Pereira (686134)